Pages

Thursday, April 21, 2016

FDA Issues Guidance for Hospitals and Health Systems Engaged in Drug Compounding | JD Supra

FDA interprets the FDCA not to permit compounding for “office use” under Section 503A; compounding ...

No comments:

Post a Comment